Today's Health News

Effectiveness Similar for First-Line ACE Inhibitors, ARBs in HTN

Risks for angioedema, cough, pancreatitis, and GI bleeding significantly lower with ARBs for first-line HTN treatment

Most Inflammatory, Cardiac Manifestations of MIS-C Resolve

Most inflammatory markers normalized by one to four weeks; however, elevated double-negative T cells seen in 92 percent at one to four months

Risk Factors ID’d for VTE, ASCVD in Rheumatoid Arthritis Patients

Risk for atherosclerotic cardiovascular disease increased twofold after unprovoked VTE in rheumatoid arthritis

Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices

Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery

Even Limited Breastfeeding May Lower Child Blood Pressure

No significant dose-response association seen for breastfed children according to duration or exclusivity of breastfeeding

Increasing Physical Activity After ICD Implantation May Cut Deaths

Risk for mortality reduced with increased physical activity, regardless of participation in cardiac rehabilitation

2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth

Mortality due to COVID-19 had biggest effect on decline in life expectancy for both men and women, all races examined

Prior Statin Use Linked to Reduced Risk for Death in COVID-19

Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension

No Increase in Risk With Dapagliflozin in Patients With Stage 4 CKD

Prespecified analysis of RCT shows reduced risk with dapagliflozin versus placebo for composite outcome that included kidney, CV events

Cycling Linked to Reduced All-Cause, CVD Mortality in Diabetes

Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week